Skip to product information
1 of 1

Cambridge University Press

The Clozapine Handbook: Stahl's Handbooks

The Clozapine Handbook: Stahl's Handbooks

Regular price $51.99 USD
Regular price Sale price $51.99 USD
Sale Sold out
Shipping calculated at checkout.
Format
Quantity
Real-world and clinical trial data support that clozapine is the only effective antipsychotic for treatment resistant schizophrenia and other severe mental illnesses. Clozapine also reduces rates of suicidality, psychiatric hospitalization and all-cause mortality. However, clozapine is underutilized for two reasons: misunderstandings of its efficacy benefits and misapprehension of, limited knowledge or misinformation about the management of treatment related risks and adverse effects. In response to worldwide efforts to promote clozapine use, this user-friendly Handbook provides clinicians with evidence-based approaches for patient management, as well as logical approaches to the management of clinical situations and adverse effects. It outlines clearly the rationale for specific management decisions and prioritises the options based on this logic. This Handbook is designed for use by clinicians worldwide and is essential reading for all mental health care professionals.

Author: Jonathan M. Meyer, Stephen M. Stahl
Publisher: Cambridge University Press
Published: 05/16/2019
Pages: 326
Binding Type: Paperback
Weight: 0.70lbs
Size: 8.20h x 8.40w x 0.50d
ISBN: 9781108447461

About the Author
Meyer, Jonathan M.: - Jonathan M. Meyer is currently a Clinical Professor of Psychiatry at the University of California, San Diego and a Psychopharmacology Consultant to the California Department of State Hospitals. Dr Meyer is an internationally recognised speaker on psychopharmacology and the treatment of severe mental illness, and is Distinguished Fellow of the American Psychiatric Association.Stahl, Stephen M.: - Stephen M. Stahl is currently a Professor at the University of California, San Diego and serves as Honorary Fellow in the psychiatry department at the University of Cambridge. He is also the Chairman of the Neuroscience Education Institute (NEI) and Arbor Scientia Group. Dr Stahl serves as the Director of Psychopharmacology Services at the California Department of State Hospitals as well as the Editor-in Chief of CNS Spectrums.

View full details